心脏骤停者的降温治疗与目前公认的其他疗法效价相当 Cooling Therapy For Cardiac Arrest Survivors Is As Cost-Effective As Accepted Treatments For Other Conditions
94，700/QALY。
Merchant表示：“我们证明，降温治疗对成本而言颇具价值。” “事实上，即使医院每年只有一名患者适合降温治疗，而幸存者的复苏后医疗成本又相当可观，其成本效益也与许多得到广泛接受的医疗干预措施相一致。”
目前该研究的局限性之一是缺乏长期观察数据，Merchant希望将来的研究会克服这一问题。
Notes:
Co-authors are Lance B. Becker， M.D.; Benjamin S. Abella， M.D.， M.Phil.; David A. Asch， M.D.， M.B.A. and Peter W. Groeneveld， M.D.， M.S. Individual author disclosures are on the manuscript.
The study was funded by the Robert Wood Johnson Foundation’s Clinical Scholars program at the University of Pennsylvania (Dr. Merchant)， and by a Career Development Transition Award from the Veterans Affairs Health Services Research and Development Service (Dr. Groeneveld).
Source:
Tagni McRae
American Heart Association
上一页 [1] [2] [3] [4] [5] [6]